Gian-Matteo Pica

1.3k total citations
16 papers, 729 citations indexed

About

Gian-Matteo Pica is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Gian-Matteo Pica has authored 16 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Gian-Matteo Pica's work include Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Gian-Matteo Pica is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Gian-Matteo Pica collaborates with scholars based in Italy, France and Portugal. Gian-Matteo Pica's co-authors include Marzia Varettoni, Alessandro Corso, Mario Lazzarino, Silvia Mangiacavalli, C. Pascutto, Patrizia Zappasodi, Catherine Klersy, Simona Fisogni, Caterina Giovanna Valentini and Pier Paolo Piccaluga and has published in prestigious journals such as Blood, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Gian-Matteo Pica

15 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gian-Matteo Pica Italy	8	438	418	230	192	129	16	729
Marc Wetterwald France	12	479 1.1×	480 1.1×	327 1.4×	208 1.1×	132 1.0×	16	869
Alfonso Maria D’Arco Italy	13	269 0.6×	264 0.6×	95 0.4×	201 1.0×	248 1.9×	27	819
Akihiro Kitadate Japan	15	193 0.4×	191 0.5×	310 1.3×	104 0.5×	84 0.7×	57	710
Tariq Muzzafar United States	14	149 0.3×	152 0.4×	95 0.4×	84 0.4×	176 1.4×	34	507
Atto Billio Italy	15	331 0.8×	209 0.5×	52 0.2×	95 0.5×	257 2.0×	37	840
Eulogio Conde Spain	15	186 0.4×	408 1.0×	148 0.6×	117 0.6×	186 1.4×	43	869
Andres Quesada United States	15	234 0.5×	135 0.3×	125 0.5×	49 0.3×	206 1.6×	59	639
Dimitra Anagnostou Greece	16	188 0.4×	169 0.4×	110 0.5×	58 0.3×	251 1.9×	41	700
Don Milligan United Kingdom	13	637 1.5×	327 0.8×	231 1.0×	19 0.1×	384 3.0×	26	1.1k
Anna Mestice Italy	17	554 1.3×	143 0.3×	275 1.2×	9 0.0×	227 1.8×	39	870

Countries citing papers authored by Gian-Matteo Pica

Since Specialization

Citations

This map shows the geographic impact of Gian-Matteo Pica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian-Matteo Pica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian-Matteo Pica more than expected).

Fields of papers citing papers by Gian-Matteo Pica

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gian-Matteo Pica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian-Matteo Pica. The network helps show where Gian-Matteo Pica may publish in the future.

Co-authorship network of co-authors of Gian-Matteo Pica

This figure shows the co-authorship network connecting the top 25 collaborators of Gian-Matteo Pica. A scholar is included among the top collaborators of Gian-Matteo Pica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian-Matteo Pica. Gian-Matteo Pica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Pica, Gian-Matteo, et al.. (2025). Dive into a trustworthy trip: Developing a multi-dimensional questionnaire to evaluate trust in autonomous vehicles. Work. 83(1). 24–32.

Cony‐Makhoul, Pascale, Sylvain Thépot, Thomas Cluzeau, et al.. (2020). Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myélodysplasies (GFM). Blood. 136(Supplement 1). 42–43. 2 indexed citations

Foltz, Lynda, Gian-Matteo Pica, Hacène Zerazhi, et al.. (2019). Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available. Leukemia & lymphoma. 60(14). 3493–3502. 3 indexed citations

Obéric, Lucie, Mathieu Puyade, Frédéric Peyrade, et al.. (2019). Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa. Blood. 134(Supplement_1). 352–352. 6 indexed citations

Foltz, Lynda, Gian-Matteo Pica, Hacène Zerazhi, et al.. (2018). Updated Results from an Open-Label, Multicenter, Expanded Treatment Protocol (ETP) Phase (Ph) 3b Study of Ruxolitinib (RUX) in Patients (Pts) with Polycythemia Vera (PV) Who Were Hydroxyurea (HU) Resistant or Intolerant and for Whom No Alternative Treatment (Tx) Was Available. Blood. 132(Supplement 1). 1774–1774. 3 indexed citations

Rossi, Giuseppe, Cristina Skert, Enrico Morello, et al.. (2014). PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G‐CSF mobilization. Hematological Oncology. 33(3). 125–132. 16 indexed citations

Carella, Angelo Michele, Giovanni Beltrami, Gian-Matteo Pica, et al.. (2012). Inhibition of autophagy with clarithromycin: a new strategy to enhance sensitivity of CML stem cells to tyrosine kinase inhibitors. PubMed. 1(S2). S49–S50. 5 indexed citations

Pagano, Livio, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.. (2012). Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 98(2). 239–246. 208 indexed citations

Miglino, Maurizio, Nicoletta Colombo, Gian-Matteo Pica, et al.. (2011). WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia. Leukemia & lymphoma. 52(10). 1961–1969. 32 indexed citations

10.

Pica, Gian-Matteo, Stefano Vagge, Giovanni Beltrami, et al.. (2011). A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation. Blood. 118(21). 4523–4523. 1 indexed citations

11.

Pica, Gian-Matteo, S Nati, Umberto Vitolo, et al.. (2011). Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study. Blood. 118(21). 100–100. 1 indexed citations

12.

Varettoni, Marzia, Alessandro Corso, Federica Cocito, et al.. (2010). Changing Pattern of Presentation in Monoclonal Gammopathy of Undetermined Significance. Medicine. 89(4). 211–216. 14 indexed citations

13.

Carella, Angelo Michele, Anna Garuti, Gabriella Cirmena, et al.. (2009). Kinase domain mutations of BCR-ABL identified at diagnosis before imatinib-based therapy are associated with progression in patients with high Sokal risk chronic phase chronic myeloid leukemia. Leukemia & lymphoma. 51(2). 275–278. 20 indexed citations

14.

Varettoni, Marzia, Alessandro Corso, Gian-Matteo Pica, et al.. (2009). Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Annals of Oncology. 21(2). 325–330. 325 indexed citations

15.

Corso, Alessandro, Marzia Varettoni, Patrizia Zappasodi, et al.. (2007). A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma. Leukemia. 21(7). 1545–1548. 85 indexed citations

16.

Zappasodi, Patrizia, Alessandro Corso, Catherine Klersy, et al.. (2006). Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience. European Journal of Cancer. 42(3). 396–402. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact